戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ve alternative access route commonly used in pulmonary artery catheterization.
2 ve correlated well with data obtained during pulmonary artery catheterization.
3 the hemodynamic data that can be obtained by pulmonary artery catheterization.
4 sus is that each method correlates well with pulmonary artery catheterization.
5 ribing their clinical use in comparison with pulmonary artery catheterization.
6 elation to the traditional data derived from pulmonary artery catheterization.
7 equential intensive care patients undergoing pulmonary artery catheterization.
8 44% vs. 42%; inotropic support, 31% vs. 31%; pulmonary artery catheterization, 11% vs. 12%; cardiopul
9  more vasopressors (68% vs. 41%), to undergo pulmonary artery catheterization (9% vs. 4%), and to die
10  and Drug Administration (FDA) conducted the Pulmonary Artery Catheterization and Clinical Outcomes w
11 ails of a donor-management pathway that uses pulmonary artery catheterization and hormonal resuscitat
12        Invasive monitors for blood pressure, pulmonary artery catheterization, and echocardiography a
13 ra-operative transesophageal echocardiogram, pulmonary artery catheterization, cardiopulmonary bypass
14 included intubation, mechanical ventilation, pulmonary artery catheterization, continuous renal repla
15 rsy surrounding the risks versus benefits of pulmonary artery catheterization, current research is fo
16 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE)
17 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE)
18 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness [ESCAPE];
19 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness trial and
20 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness trial lim
21 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness trial, th
22 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) database
23 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) trial an
24 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) trial we
25 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness], CHARM [
26 uation Study of Congestive Heart Failure and Pulmonary Artery Catheterization (ESCAPE).
27 with reduced ejection fraction who underwent pulmonary artery catheterization for advanced heart fail
28                                              Pulmonary artery catheterization is considered, by most,
29  accurate as bolus thermodilution and, since pulmonary artery catheterization is not needed, it has t
30                                              Pulmonary artery catheterization may be required to conf
31 icenter population of HF patients undergoing pulmonary artery catheterization (PAC).
32  from 1970 through 1996, using the headings "pulmonary artery catheterization," "Swan-Ganz catheteriz
33 rwent invasive hemodynamic measurements with pulmonary artery catheterization to define Starling and
34 7.8+/-3 years old; 6 women, 6 men) underwent pulmonary artery catheterization to define Starling and
35            All animals underwent percutanous pulmonary artery catheterization to measure right heart
36                                              Pulmonary artery catheterization was performed before an
37  HF with reduced ejection fraction underwent pulmonary artery catheterization with blood sampling fro
38                  Each subject also underwent pulmonary artery catheterization with measurement of pul
39 by the noninvasive methods parallel those of pulmonary artery catheterization, with the exclusion of